This chapter aims at summarizing current knowledge on experimental systems for analyzing the role of white matter injury relevant to stroke. In this chapter, we will provide a broad but brief survey of existing models at the cell, tissue, and whole-animal levels. Experimental approaches have recently allowed a better understanding of the molecular and cellular pathways underlying oligodendrocyte and oligodendrocyte precursor cell damage and demyelination. Since white matter damage is a clinically important part of stroke, a systematic utilization of these cell/ tissue/whole-animal platforms related to white matter pathophysiology may eventually lead us to discover new targets for treating stroke.
CITATION STYLE
Arai, K., Loc-Duyen, D. P., & Lo, E. H. (2012). Experimental platforms for assessing white matter pathophysiology in stroke. In Translational Stroke Research: From Target Selection to Clinical Trials (pp. 57–78). Springer New York. https://doi.org/10.1007/978-1-4419-9530-8_3
Mendeley helps you to discover research relevant for your work.